Latest studies suggest a possible downturn in rate of new cases of diabetes

September 15, 2019

While overall, the numbers (prevalence) of people with type 2 diabetes continue to grow at an alarming rate, new research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 September) shows that recent studies suggest the rate at which new cases develop (incidence) may be falling. The study is by Professor Dianna Magliano and Professor Jonathan Shaw, Baker Heart and Diabetes Institute, Melbourne, Australia, and colleagues.

According to the International Diabetes Federation, approximately 425 million adults (aged 20-79 years) were living with diabetes in 2017; by 2045 this is expected rise above 600 million. However, because care is improving and people are surviving longer, the number of people with diabetes does not accurately show population-level risk of new cases developing. Diabetes incidence (the number of new cases per year) is a better way to understand the population risk of diabetes.

The authors searched the MEDLINE, EMBASE and CINAHL databases for publications between January 1980 and August 2018. Studies were included if they were of population-based cohorts, occupational groups, and health examination or primary care cohorts, with at least 2 years of follow-up, reported incidence of diabetes or type 2 diabetes in adults, and published in English.

A mid-point was estimated in each study's follow-up period to categorise the study into one of five time periods (1970-79, 1980-89, 1990-99, 2000-09, and 2010 onwards). Diabetes incidence was modelled by age group and adjusted for mid-point of baseline year, ethnicity, and method used in the diagnosis of diabetes at follow-up using statistical modelling.

A total of 275 articles met the inclusion criteria, mostly from high-income countries. The overall crude annualised diabetes incidence rose from 0.53% (5.3 new cases per 1000 population per year) in the 1970s to 1.0% (10 new cases per 1000 persons per year) in the 2010s. Compared to persons aged 35 years and under, the incidence rate was around double in those aged 35-44 years and 45-54 years; trebled in those aged 55-65 years, and increased 4-fold in people aged 65 years and older.

Compared to studies with a mid-point of baseline year in 1990s, the incidence rate was 20% was higher in studies with a mid-point in 2000-2009; however, when looking at studies from 2010 onwards, diabetes incidence was no longer increasing -- there was a 5% decrease in incidence that did not reach statistical significance. The authors say: "It therefore appears that following the rise in incidence from 1990s there was a flattening or even a possible decline in the rate of new cases of type 2 diabetes in the last few years."

Compared to studies with people of predominantly European ancestry, the incidence was higher in studies of Africans, Asians, Hispanics/Mexicans, and in Indigenous populations. In Africans, diabetes incidence was 60% higher; in Asian populations, incidence was 30% higher, and in Hispanic populations, it was 80% higher. For Middle Eastern and Pacific Islander populations, there was no statistically significant increased incidence, but the authors suggest this could be due to low overall numbers of studies measuring incidence in these populations included in the review.

The authors say: "The rate of new cases (incidence) of diabetes, mainly type 2 diabetes, continued to rise among people aged 35 years and above over the last four decades, with the highest rate observed in studies beginning around 2000-04. Studies that began in 2010 and later suggested a possible downturn in incidence. Further investigations are required to establish the trends in different region/ethnic subgroups."

They add: "If these trends continue, it may mean that incidence is starting to stabilise and this could indicate that prevention and public health activities may have had an effect. Lower levels of screening for diabetes may have played a role, and it is also possible that depletion of susceptible people may be involved. In reality, it is probably a combination of all these factors."

Regarding the pool of susceptible people, the authors explain: "It has been suggested that we might have depleted the pool of susceptible people who could have developed diabetes and that is why we are not diagnosing as many new cases now. This assumes that there is a group of people who are at risk of diabetes and that some people, despite what they do, won't ever get diabetes. This is a very difficult concept to test and we have not worked out how to explore this."

And on the overall findings in this work, the authors conclude: "We need to be clear that although incidence may be decreasing, prevalence is still increasing and we cannot be complacent. This work tells us have we may be cautiously optimistic about the global diabetes epidemic and we should continue implementing strategies for diabetes prevention to ensure incidence does not increase again."


Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to